MedTrace Logo

Metabonomics Study of Chronic Gastritis and Gastric Carcinoma

NCT04624282 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-01-20

No results posted yet for this study

Summary

The pathogenetic mechanisms of chronic gastritis and gastric carcinoma are different. Whether metabonomics play a role in the development of chronic gastritis and gastric cancer is still a question. So the investigators want to clarify this question by this subject.

Conditions

Interventions

DIAGNOSTIC_TEST

different diseases

Patients will be divided into three groups, including chronic superficial gastritis ,chronic atrophic gastritis and gastric carcinoma.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Yuehua Han, Dr. · 2nd Affiliated Hospital, School of Medicine, Zhejiang university, China

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-04-30
Completion
2021-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624282 on ClinicalTrials.gov